{"ORPHApacket":[{"ORPHApacketID":"99741","date":"2019-12-05 21:28:43","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"99741","Name":[{"lang":"en","label":"King-Denborough syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_99741","DisorderType":[{"Name":[{"lang":"en","label":"Malformation syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377789"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Malformation syndrome with short stature"}],"ORPHA":"139021","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_139021"},{"Name":[{"lang":"en","label":"Multiple congenital anomalies\/dysmorphic syndrome-variable intellectual disability syndrome"}],"ORPHA":"102284","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_102284"},{"Name":[{"lang":"en","label":"Neurological muscular channelopathy due to a genetic ryanodine receptor defect"}],"ORPHA":"98742","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_98742"},{"Name":[{"lang":"en","label":"Congenital myopathy"}],"ORPHA":"97245","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_97245"},{"Name":[{"lang":"en","label":"Rare disease with malignant hyperthermia"}],"ORPHA":"466658","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_466658"},{"Name":[{"lang":"en","label":"Genetic malformation syndrome with short stature"}],"ORPHA":"183570","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_183570"},{"Name":[{"lang":"en","label":"Genetic multiple congenital anomalies\/dysmorphic syndrome-variable intellectual disability syndrome"}],"ORPHA":"330197","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_330197"},{"Name":[{"lang":"en","label":"Rare disease in anaesthesiology"}],"ORPHA":"98032","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_98032"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"King-Denborough syndrome is a rare genetic non-dystrophic myopathy characterized by the triad of congenital myopathy, dysmorphic features and susceptibility to malignant hyperthermia. Patients present with a wide phenotypic range, including delayed motor development, muscle weakness and fatigability, ptosis and facies myopathica (with or without creatine kinase elevations), skeletal abnormalities (e.g. short stature, scoliosis, kyphosis, lumbar lordosis and pectus carinatum\/excavatum), mild dysmorphic facial features (e.g. hypertelorism, down-slanting palpebral fissures, epicanthic folds, low set ears, micrognathia), webbing of the neck, cryptorchidism, and a susceptibility to malignant hyperthermia and\/or rhabdomyolysis due to intensive physical strain, viral infection or statin use."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"145600","DisorderMappingRelation":[{"id":"21534","Name":[{"lang":"en","label":"NTBT (narrower term maps to a broader term)"}]}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal dominant"}]}]}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"Koussef-Nichols syndrome"}]}]}]}